| Year |
Citation |
Score |
| 2017 |
Farizatto KLG, McEwan SA, Naidoo V, Nikas SP, Shukla VG, Almeida MF, Byrd A, Romine H, Karanian DA, Makriyannis A, Bahr BA. Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo Neurotoxic Effects of Paraoxon. Journal of Molecular Neuroscience : Mn. PMID 28803438 DOI: 10.1007/S12031-017-0963-4 |
0.686 |
|
| 2012 |
Naidoo V, Karanian DA, Vadivel SK, Locklear JR, Wood JT, Nasr M, Quizon PM, Graves EE, Shukla V, Makriyannis A, Bahr BA. Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 9: 801-13. PMID 22270809 DOI: 10.1007/S13311-011-0100-Y |
0.672 |
|
| 2011 |
Naidoo V, Nikas SP, Karanian DA, Hwang J, Zhao J, Wood JT, Alapafuja SO, Vadivel SK, Butler D, Makriyannis A, Bahr BA. A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity. Journal of Molecular Neuroscience : Mn. 43: 493-502. PMID 21069475 DOI: 10.1007/S12031-010-9472-4 |
0.707 |
|
| 2007 |
Williams J, Wood J, Pandarinathan L, Karanian DA, Bahr BA, Vouros P, Makriyannis A. Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. Analytical Chemistry. 79: 5582-93. PMID 17600384 DOI: 10.1021/Ac0624086 |
0.55 |
|
| 2007 |
Karanian DA, Karim SL, Wood JT, Williams JS, Lin S, Makriyannis A, Bahr BA. Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage. The Journal of Pharmacology and Experimental Therapeutics. 322: 1059-66. PMID 17545313 DOI: 10.1124/Jpet.107.120147 |
0.679 |
|
| 2007 |
Kosten TA, Karanian DA, Yeh J, Haile CN, Kim JJ, Kehoe P, Bahr BA. Memory impairments and hippocampal modifications in adult rats with neonatal isolation stress experience. Neurobiology of Learning and Memory. 88: 167-76. PMID 17543553 DOI: 10.1016/J.Nlm.2007.03.011 |
0.593 |
|
| 2007 |
Butler D, Bendiske J, Michaelis ML, Karanian DA, Bahr BA. Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers. European Journal of Pharmacology. 562: 20-7. PMID 17336290 DOI: 10.1016/J.Ejphar.2007.01.053 |
0.612 |
|
| 2006 |
Karanian DA, Bahr BA. Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states. Current Molecular Medicine. 6: 677-84. PMID 17022737 DOI: 10.2174/156652406778194991 |
0.62 |
|
| 2006 |
Karanian DA, Baude AS, Brown QB, Parsons CG, Bahr BA. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism. Hippocampus. 16: 834-42. PMID 16897723 DOI: 10.1002/Hipo.20214 |
0.653 |
|
| 2006 |
Bahr BA, Karanian DA, Makanji SS, Makriyannis A. Targeting the endocannabinoid system in treating brain disorders. Expert Opinion On Investigational Drugs. 15: 351-65. PMID 16548785 DOI: 10.1517/13543784.15.4.351 |
0.629 |
|
| 2005 |
Butler D, Brown QB, Chin DJ, Batey L, Karim S, Mutneja MS, Karanian DA, Bahr BA. Cellular responses to protein accumulation involve autophagy and lysosomal enzyme activation. Rejuvenation Research. 8: 227-37. PMID 16313222 DOI: 10.1089/Rej.2005.8.227 |
0.691 |
|
| 2005 |
Karanian DA, Brown QB, Makriyannis A, Kosten TA, Bahr BA. Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 7813-20. PMID 16120783 DOI: 10.1523/Jneurosci.2347-05.2005 |
0.677 |
|
| 2005 |
Karanian DA, Brown QB, Makriyannis A, Bahr BA. Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus. European Journal of Pharmacology. 508: 47-56. PMID 15680253 DOI: 10.1016/J.Ejphar.2004.12.009 |
0.632 |
|
| Show low-probability matches. |